Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $102.67 ($317K) on 2015-11-02, disclosed to the SEC on 2015-11-03.
Scheduled sale ($317k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.82 | 89 | $9K | 2.8% |
| 2 | $100.80 | 111 | $11K | 3.5% |
| 3 | $102.67 | 100 | $10K | 3.2% |
| 4 | $104.28 | 500 | $52K | 16.5% |
| 5 | $105.10 | 400 | $42K | 13.3% |
| 6 | $106.33 | 1,000 |
| $106K |
| 33.6% |
| 7 | $107.29 | 700 | $75K | 23.7% |
| 8 | $108.16 | 100 | $11K | 3.4% |
| Total | $105.56 avg | 3,000 | $317K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |
| CLVS | SELL | 2015-09-03 | $239K | — | Filing → |